Bicycle Therapeutics Ltd of Cambridge, UK has opened a new office in Cambridge, Massachusetts and named Rosamond Deegan as president and chief business officer. Ms Deegan will be responsible for expanding the company’s operations in the US. Bicycle is developing therapeutics for oncology based on a new class of peptides. Ms Deegan was previously head of business development at Trevena Inc and before that, directed business development at GlaxoSmithKline Plc in the US.
Bicycle Therapeutics announced the appointment on 23 May 2016.
Copyright 2016 Evernow Publishing Ltd